Filter
7825
Filtered Results: 7825
Text search:
safety
Featured
Recommendations
792
New Publications
1977
Language
Document type
No document type
3986
Guidelines
1215
Studies & Reports
1179
Manuals
466
Strategic & Response Plan
292
Fact sheets
269
Training Material
148
Situation Updates
97
Resource Platforms
45
Infographics
45
Brochures
28
Videos
27
Online Courses
26
App
2
Countries / Regions
India
286
Global
286
Kenya
193
Sierra Leone
170
South Africa
151
Liberia
147
Western and Central Europe
141
Nigeria
137
Ethiopia
137
Syria
137
Myanmar / Burma
136
Uganda
119
Nepal
113
Latin America and the Carribbean
109
Bangladesh
107
Africa
100
Indonesia
91
Ukraine
89
Malawi
86
Rwanda
79
Zambia
77
Tanzania
77
Ghana
74
South Sudan
66
Congo, Democratic Republic of
65
Philippines
65
Russia
61
Guinea
57
Namibia
56
Yemen
56
Brazil
53
West and Central Africa
53
Middle East and North Africa
48
Germany
46
East and Southern Africa
43
South–East Asia Region
43
Senegal
41
Haiti
40
Mozambique
39
Zimbabwe
37
Lesotho
37
Eastern Europe
36
Burkina Faso
35
Eastern Europe and Central Asia
34
Cambodia
33
Asia
32
Botswana
29
Mali
28
Lebanon
26
Afghanistan
25
Venezuela
25
Pakistan
24
Eswatini/ Swaziland
24
USA
22
Sudan
21
Central African Republic
20
Vietnam
19
Jordan
18
Colombia
18
Angola
18
Chile
17
Cameroon
16
Western Pacific Region
15
Côte d’Ivoire / Ivory Coast
14
Somalia
14
Thailand
14
Argentina
14
Peru
14
Guinea-Bissau
13
Iraq
13
Niger
11
China
11
Ecuador
11
Laos
11
Turkey
10
Libya
10
Tajikistan
10
Moldova
10
Palestine
9
United Kingdom
9
Benin
8
Bolivia
8
Madagascar
8
Albania
8
Spain
8
Chad
7
Greece
7
Sri Lanka
7
Paraguay
7
Papua New Guinea
6
Bhutan
6
Portugal
6
Saudi Arabia
5
Gambia
5
Singapore
5
Iran
5
Kazakhstan
5
North America
5
Egypt
4
Burundi
4
El Salvador
4
Poland
4
Southern Africa
4
Timor Leste/ East Timor
4
Romania
4
Kyrgyzstan
4
Georgia
4
Turkmenistan
4
Japan
4
Tunisia
4
Morocco
3
Togo
3
North Macedonia
3
Croatia
3
Guatemala
3
Mexico
3
Canada
3
Qatar
3
Uzbekistan
3
Mauritius
3
Belarus
3
Israel
3
Bosnia and Herzegovina
3
Mauritania
2
Dominican Republic
2
Switzerland
2
Serbia
2
Hungary
2
Honduras
2
Nicaragua
2
Fiji
2
Italy
2
Djibouti
2
Estonia
2
Lithuania
2
Gabon
2
France
2
Algeria
2
Malaysia
1
Ireland
1
Austria
1
Cuba
1
Armenia
1
Congo-Brazzaville
1
Bulgaria
1
Australia
1
Jamaica
1
Denmark
1
Belgium
1
Maldives
1
South Korea
1
Azerbaijan
1
French Guyana
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
2678
Clinical Guidelines
583
Key Resources
500
Women & Child Health
427
Public Health
389
Capacity Building
153
Pharmacy & Technologies
105
Toolboxes
COVID-19
1077
Mental Health
572
HIV
419
Ebola
303
Conflict
302
Planetary Health
296
AMR
281
TB
272
Caregiver
268
Rapid Response
246
Disability
237
Refugee
213
Pharmacy
204
Natural Hazards
172
Global Health Education
133
NTDs
114
NCDs
112
Specific Hazards
74
Cholera
58
Zika
50
Polio
37
Health Financing Toolbox
33
Social Ethics
23
Typhoon
5
South Sudan
2
Health Financing
1
This decision tree guides data collectors through the various considerations, viable options, and alternative data sources for obtaining information without jeopardizing participants’ safety or the data’s integrity. In doing so, it aims to ident...
The package provides practical, concise yet crucial information about the impact of COVID-19 on daily teaching practices as well as tips and suggestions to improve safety, well-being and learning, with students in face-to-face or remote settings.
...
The package provides practical, concise yet crucial information about the impact of COVID-19 on daily teaching practices as well as tips and suggestions to improve safety, well-being and learning, with students in face-to-face or remote settings.
...
Оказание поддержки специалистам-практикам и лицам, ответственным за разработку политики в области защиты детей, с целью поставить безопасность и благополучие реб...
Focusing on preventing and mitigating COVID-19 related risks, the standards aim to protect the health and safety of personnel, while ensuring that organizations continue to deliver on their mandates. Attention is paid to non-discrimination and ensur...
As vaccines get approved by national authorities, learn about National and WHO approval processes for vaccines and how safety is ensured during emergency approval of vaccines. Dr Mariângela Simão explains in Science in 5.
The European Medicines Agency (EMA) is evaluating potential COVID-19 treatments and vaccines to enable promising medicines to reach patients as soon as possible. It is also interacting with medicine developers and making use of real-world data to monitor the ... and effectiveness of medicines used in patients with COVID-19.
August 2020, The Africa Joint Continental Strategy for COVID-19 is underpinned by the need to limit transmission, prevent deaths and reduce associated harms. Participation by African nations in clinical trials is an essential step to ensure that sufficient data is generated on the ... and efficacy of the most promising vaccine candidates among the region’s populations.
While current COVID-19 clinical trial activity on the continent is limited, Africa has substantial experience and capabilities to conduct clinical trials for preventative vaccines across a range of diseases, and many organizations on the continent are working tirelessly to help prepare additional trials on potential COVID-19 vaccines. As the number of candidate vaccines in the development pipeline continues to increase, it will be important for organizations responsible for managing clinical trials in the region to partner with vaccine developers to identify potential and appropriate trial locations, provide support to remove any critical obstacles impeding commencement and progress of trials, and to provide oversight ensuring that trials are conducted safely and ethically.
COVAXINTM, India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV). The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech's BSL-3 (Bio-... Level 3) high containment facility.
The vaccine received DCGI approval for Phase I & II Human Clinical Trials and the trials commenced across India from July, 2020.
After successful completion of the interim analysis from the Phase 1 & 2 clinical trials of COVAXINTM, Bharat Biotech received DCGI approval for Phase 3 clinical trials in 26,000 participants in over 25 centres across India.
WHO PQS Devices Catalogue. Pre-qualified equipment for the Expanded Programme on Immunization (EPI)
recommended
The PQS on-line catalogue includes details of all immunization-related products currently pre-qualified by WHO for procurement by United Nations agencies. The catalogue is produced and maintained by the Quality, Safety and Standards group in the Imm...
How far apart should the doses of vaccines be? What if I miss my second dose? Can I get two doses from two different manufacturers? How was safety of vaccines ensured? WHO’s Chief Scientist, Dr Soumya Swaminathan explains in Science in 5.
17 February 2021
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explain...
Workplaces have played an important role in both the spread and mitigation of the COVID-19 pandemic throughout the world. Being provided a healthy and safe workplace throughout the pandemic and beyond is a human right. Maintaining open, safe and healthy workplaces is of vital importance to protectin...
1 March 2021
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained s...
31 March 2021
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained ...
31 March 2021
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained ...
Orientations provisoires, 2 février 2021
e document est une mise à jour des orientations provisoires de l’Organisation mondiale de la Santé (OMS) intitulées Coronavirus disease (COVID-19) outbreak: rights, roles and responsibilities of health workers, including key considerations...
Interim guidance 2 February 2021 . Available in Arabic, Chinese, English, French, Ukranian, Russian
Health workers are at the front line of the COVID-19 outbreak response and as such are exposed to different hazards that put them at risk. Occupational hazards include exposure to SARS-CoV-2 and othe...
Why does WHO recommend at this time, in June 2021, that vaccinating children is not a priority? When would their vaccination be prioritized? How is safety of these vaccines ensured? WHO’s Chief Scientist Dr Soumya Swaminathan explains in Science ...
14 July 2021 This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained se...
